Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% ...

The promise of messenger RNA (mRNA) has moved far beyond its pandemic-era spotlight. In oncology, mRNA has emerged as a ...

Johnson & Johnson Vietnam has partnered with Ho Chi Minh City Oncology Hospital to improve treatment for lung and prostate cancers through the first memorandum of understanding (MoU) signed between ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

The global prostate cancer diagnostics market is expected to grow at a CAGR of ~12% during the forecast period. Rising ...

Circulating tumor DNA (ctDNA), small pieces of DNA released from dying tumor cells into the bloodstream, can be easily and non-invasively identified and ex | Cancer ...

The Business Research Company’s Somatic Genetic Testing Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 ...

Pacific Emerges as Fastest-Growing Region at 25.4% CAGR, Driven by Expanding Clinical Adoption and Falling Sequencing Costs.Pune, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Whole Genome Sequencing Market ...

Discover why Fulgent’s accelerating revenue and rising margins signal growth potential, with shares undervalued vs. cash.

An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based ...

Revenue generated from pharma research and development services was RMB45.2 million (US$6.3 million) for the three months ended June 30, 2025, representing a 68.1% increase from RMB26.9 million for ...

Every three seconds, one life is lost to sepsis, according to the Global Sepsis Alliance. It is a life-threatening, dysregulated immune response to infection and remains a leading cause of death ...